NM_000453.3:c.1652-9G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000453.3(SLC5A5):​c.1652-9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,597,824 control chromosomes in the GnomAD database, including 38,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3029 hom., cov: 31)
Exomes 𝑓: 0.22 ( 35820 hom. )

Consequence

SLC5A5
NM_000453.3 intron

Scores

2
Splicing: ADA: 0.00005823
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.00600

Publications

12 publications found
Variant links:
Genes affected
SLC5A5 (HGNC:11040): (solute carrier family 5 member 5) This gene encodes a member of the sodium glucose cotransporter family. The encoded protein is responsible for the uptake of iodine in tissues such as the thyroid and lactating breast tissue. The iodine taken up by the thyroid is incorporated into the metabolic regulators triiodothyronine (T3) and tetraiodothyronine (T4). Mutations in this gene are associated with thyroid dyshormonogenesis 1.[provided by RefSeq, Sep 2009]
SLC5A5 Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-17890877-G-A is Benign according to our data. Variant chr19-17890877-G-A is described in ClinVar as Benign. ClinVar VariationId is 256199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC5A5NM_000453.3 linkc.1652-9G>A intron_variant Intron 13 of 14 ENST00000222248.4 NP_000444.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC5A5ENST00000222248.4 linkc.1652-9G>A intron_variant Intron 13 of 14 1 NM_000453.3 ENSP00000222248.2

Frequencies

GnomAD3 genomes
AF:
0.187
AC:
28314
AN:
151740
Hom.:
3026
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.122
Gnomad AMI
AF:
0.0945
Gnomad AMR
AF:
0.167
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.0118
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.235
Gnomad OTH
AF:
0.186
GnomAD2 exomes
AF:
0.179
AC:
44669
AN:
249144
AF XY:
0.183
show subpopulations
Gnomad AFR exome
AF:
0.121
Gnomad AMR exome
AF:
0.114
Gnomad ASJ exome
AF:
0.234
Gnomad EAS exome
AF:
0.00669
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.231
Gnomad OTH exome
AF:
0.196
GnomAD4 exome
AF:
0.216
AC:
312877
AN:
1445966
Hom.:
35820
Cov.:
29
AF XY:
0.214
AC XY:
154331
AN XY:
720230
show subpopulations
African (AFR)
AF:
0.123
AC:
4069
AN:
33150
American (AMR)
AF:
0.122
AC:
5449
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.232
AC:
6034
AN:
26036
East Asian (EAS)
AF:
0.0258
AC:
1023
AN:
39628
South Asian (SAS)
AF:
0.130
AC:
11177
AN:
85910
European-Finnish (FIN)
AF:
0.246
AC:
13143
AN:
53358
Middle Eastern (MID)
AF:
0.256
AC:
1363
AN:
5314
European-Non Finnish (NFE)
AF:
0.235
AC:
258556
AN:
1098012
Other (OTH)
AF:
0.202
AC:
12063
AN:
59856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
11857
23713
35570
47426
59283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8614
17228
25842
34456
43070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.187
AC:
28336
AN:
151858
Hom.:
3029
Cov.:
31
AF XY:
0.185
AC XY:
13735
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.122
AC:
5039
AN:
41422
American (AMR)
AF:
0.167
AC:
2540
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
820
AN:
3468
East Asian (EAS)
AF:
0.0118
AC:
61
AN:
5168
South Asian (SAS)
AF:
0.121
AC:
580
AN:
4810
European-Finnish (FIN)
AF:
0.265
AC:
2795
AN:
10528
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.235
AC:
15945
AN:
67922
Other (OTH)
AF:
0.190
AC:
400
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1142
2285
3427
4570
5712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.218
Hom.:
5542
Bravo
AF:
0.176
Asia WGS
AF:
0.0890
AC:
309
AN:
3478
EpiCase
AF:
0.237
EpiControl
AF:
0.236

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Thyroid dyshormonogenesis 1 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
2.7
DANN
Benign
0.62
PhyloP100
-0.0060
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000058
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4808708; hg19: chr19-18001686; API